1-Hydroxy-1,8-naphthyridin-2(1H)-one | 1258547-13-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二氮杂萘
• 英文名称: 1-Hydroxy-1,8-naphthyridin-2(1H)-one
• 英文别名: 1-Hydroxy-1,8-naphthyridin-2-one
• CAS: 1258547-13-5
• 化学式: C₈H₆N₂O₂
• 分子量: 162.148
• InChiKey: KAVCEKUOAXQRPZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.3
• 重原子数：
  12
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  53.4
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  (1-benzyloxy-2-oxo-1,8-naphthyridin-4-yl) trifluoromethanesulfonate 在 5% palladium on activated carbon 、 氢气 作用下， 以 乙酸乙酯 为溶剂， 20.0 ℃ 、101.33 kPa 条件下， 生成 1-Hydroxy-1,8-naphthyridin-2(1H)-one
  参考文献：
  名称：

  Potent and selective HIV-1 ribonuclease H inhibitors based on a 1-hydroxy-1,8-naphthyridin-2(1H)-one scaffold

  摘要：

  Optimization studies using an HIV RNase H active site inhibitor containing a 1-hydroxy-1,8-naphthyridin-2(1H)-one core identified 4-position substituents that provided several potent and selective inhibitors. The best compound was potent and selective in biochemical assays (IC(50) = 0.045 mu M, HIV RT RNase H; 13 mu M, HIV RT-polymerase; 24 mu M, HIV integrase) and showed antiviral efficacy in a single-cycle viral replication assay in P4-2 cells (IC(50) = 0.19 mu M) with a modest window with respect to cytotoxicity (CC(50) = 3.3 mu M). (C) 2010 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2010.08.135

文献信息

• [EN] ANTI-FUNGAL COMPOUNDS<br/>[FR] COMPOSÉS ANTIFONGIQUES
  申请人：UNIV SAINT LOUIS

  公开号：WO2017184752A1

  公开（公告）日：2017-10-26

  The present disclosure provides compounds of the formula (I), (II), (III), wherein the variables are as defined herein for use in the treatment of fungal infections. In some embodiments, the fungal infection is an infection of Cryptococcus neojormans fungus. Also provided herein are compositions comprising a compound of formula I, II, or III and a second anti-fungal agent.

  本公开提供式(I)、(II)、(III)的化合物，其中变量的定义如本文所述，用于治疗真菌感染。在某些实施例中，真菌感染是新隆头菌真菌感染。此外，本文还提供包括式(I)、(II)或(III)的化合物和第二种抗真菌剂的组合物。
• 1-HYDROXY NAPHTHYRIDINE COMPOUNDS AS ANTI-HIV AGENTS
  申请人：Williams Peter D.

  公开号：US20100056516A1

  公开（公告）日：2010-03-04

  1-Hydroxy naphthyridine compounds (e.g., 1-hydroxy naphthyridin-2(1H)-one compounds of Formula I are inhibitors of HIV integrase and/or HIV RNase H and inhibitors of HIV replication: (I) wherein X and R1-R6 are as defined herein. The compounds are useful in the prophylaxis and treatment of infection by HIV and in the prophylaxis, delay in the onset, and treatment of AIDS. The compounds are employed against HIV infection and AIDS as compounds per se or in the form of pharmaceutically acceptable salts. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other anti-HIV agents such as HIV antivirals, immunomodulators, antibiotics and vaccines.

  1-羟基萘啶化合物（例如，式I中的1-羟基萘啶-2（1H）-酮化合物）是HIV整合酶和/或HIV RNase H的抑制剂，也是HIV复制的抑制剂：（I）其中X和R1-R6如此定义。这些化合物对于预防和治疗HIV感染以及预防、延迟发病和治疗艾滋病非常有用。这些化合物可作为化合物本身或作为药学上可接受的盐的形式用于对抗HIV感染和艾滋病。这些化合物及其盐可作为制药组合物的成分，可以选择与其他抗HIV剂（例如HIV抗病毒药物，免疫调节剂，抗生素和疫苗）组合使用。
• Anti-fungal compounds
  申请人：SAINT LOUIS UNIVERSITY

  公开号：US10980754B2

  公开（公告）日：2021-04-20

  The present disclosure provides compounds of the formula (I), (II), (III), wherein the variables are as defined herein for use in the treatment of fungal infections. In some embodiments, the fungal infection is an infection of Cryptococcus neojormans fungus. Also provided herein are compositions comprising a compound of formula I, II, or III and a second anti-fungal agent.

  本公开提供了式(I)、(II)、(III)化合物，其中变量如本文所定义，用于治疗真菌感染。在某些实施方案中，真菌感染是新隐球菌真菌的感染。本文还提供了包含式 I、II 或 III 的化合物和第二种抗真菌剂的组合物。
• ANTI-INFECTIVE AGENTS
  申请人：Abbott Laboratories

  公开号：EP1560827A1

  公开（公告）日：2005-08-10
• COMPOSITIONS AND METHODS FOR INHIBITING RESOLVASES
  申请人：The Trustees of the University of Pennsylvania

  公开号：US20150094327A1

  公开（公告）日：2015-04-02

  The invention provides a fluorescence polarization (FP)-based assay to identify inhibitors of resolvase's DNA cleavage activity. The invention also provides resolvase inhibitors identified by the assay, as well as derivatives and analogs thereof. In certain embodiments, the compounds of the invention are useful to treat a poxvirus infection in an infected subject.